AT197762T
Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride
Abstract
Claimed is a chargeable to Jiaxi Sha Bili optical pure () and isomer composition and application method. Discovered wherein expectation the compound is a treating central nervous system disease and medicine. The discovery compounds () and removing Jiaxi sand to the wallet bag a effective and emetic. The other, removing Jiaxi Sha (Bili) and isomer further can avoid and a side effects and multiple injurious medicine the interaction.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
81 members in 32 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 68475396 | United States of America | A | |
| 9711629 | United States of America | W |
Members81
| Document | Office | Kind | |
|---|---|---|---|
| CA2245768A1 | Canada | A1 | |
| WO9803173A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3592097A | Australia | A | |
| US5739151A | United States of America | A | |
| NO983636D0 | Norway | D0 | |
| IS4820A | Iceland | A | |
| NO983636L | Norway | L | |
| EP0896539A1 | European Patent Office (EPO) | A1 | |
| US5877188A | United States of America | A | |
| SK123998A3 | Slovakia | A3 | |
| IL125703D0 | Israel | D0 | |
| CZ250898A3 | Czechia | A3 | |
| CN1215992A | China | A | |
| BG102757A | Bulgaria | A | |
| JPH11510828A | Japan | A | |
| BR9708287A | Brazil | A | |
| CA2338465A1 | Canada | A1 | |
| WO0006165A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5126099A | Australia | A | |
| PL335254A1 | Poland | A1 | |
| HU9904360A2 | Hungary | A2 | |
| HUP9904360A2 | Hungary | A2 | |
| NZ331291A | New Zealand | A | |
| US6114356A | United States of America | A | |
| JP3097697B2 | Japan | B2 | |
| TR199801816T2 | Türkiye | T2 | |
| KR20000064524A | Republic of Korea | A | |
| US6147093A | United States of America | A | |
| EP0896539B1 | European Patent Office (EPO) | B1 | |
| AT197762TThis record | Austria | T | |
| ATE197762T1 | Austria | T1 | |
| DE69703617D1 | Germany | D1 | |
| NO20010464D0 | Norway | D0 | |
| ES2152687T3 | Spain | T3 | |
| DK0896539T3 | Denmark | T3 | |
| NO20010464L | Norway | L | |
| DE69703617T2 | Germany | T2 | |
| BR9912581A | Brazil | A | |
| EP1100502A1 | European Patent Office (EPO) | A1 | |
| GR3035460T3 | Greece | T3 | |
| PT896539E | Portugal | E | |
| US6242465B1 | United States of America | B1 | |
| BG63190B1 | Bulgaria | B1 | |
| ID28894A | Indonesia | A | |
| KR20010071047A | Republic of Korea | A | |
| CO5060499A1 | Colombia | A1 | |
| HU9904360A3 | Hungary | A3 | |
| HUP9904360A3 | Hungary | A3 | |
| SK1202001A3 | Slovakia | A3 | |
| EA200100188A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2001020031A1 | United States of America | A1 | |
| TR200100921T2 | Türkiye | T2 | |
| CN1320036A | China | A | |
| BG105218A | Bulgaria | A | |
| HU0102979A2 | Hungary | A2 | |
| HUP0102979A2 | Hungary | A2 | |
| PL345764A1 | Poland | A1 | |
| CZ2001348A3 | Czechia | A3 | |
| HU0102979A3 | Hungary | A3 | |
| HUP0102979A3 | Hungary | A3 | |
| IL141047D0 | Israel | D0 | |
| HRP20010075A2 | Croatia | A2 | |
| AR019947A1 | Argentina | A1 | |
| EE200100051A | Estonia | A | |
| HK1041226A1 | Hong Kong, China | A1 | |
| JP2002521448A | Japan | A | |
| KR100328731B1 | Republic of Korea | B1 | |
| SK282673B6 | Slovakia | B6 | |
| NZ509671A | New Zealand | A | |
| KR100399808B1 | Republic of Korea | B1 | |
| CA2245768C | Canada | C | |
| US6632827B2 | United States of America | B2 | |
| KR20040007505A | Republic of Korea | A | |
| US2004044039A1 | United States of America | A1 | |
| KR100422492B1 | Republic of Korea | B1 | |
| NO20041166L | Norway | L | |
| CZ293478B6 | Czechia | B6 | |
| NO317178B1 | Norway | B1 | |
| PL189610B1 | Poland | B1 | |
| CZ295776B6 | Czechia | B6 | |
| KR100533237B1 | Republic of Korea | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Ceased due to non-payment of the annual feeCeasedREN | REN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 97932467
Titles2
- German
- VERWENDUNG VON OPTISCH REINES (+) NORCISAPRIDE ZUR BEHANDLUNG VON ERBRECHEN UND ZNS-STÖRUNGEN
- English
- USE OF OPTICALLY PURE (+) NORCISAPRIDE FOR THE TREATMENT OF CRUSH AND CNS DISORDERS
Classification
- CPC, 11
- A61K31/4468
- A61K31/445
- A61K31/495
- A61P1/08
- A61P1/14
- A61P25/00
- A61P25/04
- A61P25/14
- A61P25/18
- A61P25/22
- A61P25/24
- IPC, 13
- C07D211 58
- A61K31 00
- A61K31 445
- A61K31 4465
- A61K31 4468
- A61K31 495
- A61P1 08
- A61P1 14
- A61P25 04
- A61P25 14
- A61P25 18
- A61P25 22
- A61P25 24